Table 1 Summary of AGREE II structure and detailed list of items within each domain (from reference 15)
Domain 1. Scope and Purpose | |
Item 1 | The overall objective(s) of the guideline is (are) specifically described |
Item 2 | The health question(s) covered by the guideline is (are) specifically described |
Item 3 | The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described |
Domain 2: Stakeholder Involvement | |
Item 4 | The guideline development group includes individuals from all the relevant professional groups |
Item 5 | The views and preferences of the target population (patients, public, etc.) have been sought |
Item 6 | The target users of the guideline are clearly defined |
Domain 3: Rigor of Development | |
Item 7 | Systematic methods were used to search for evidence |
Item 8 | The criteria for selecting the evidence are clearly described |
Item 9 | The strengths and limitations of the body of evidence are clearly described |
Item 10 | The methods for formulating the recommendations are clearly described |
Item 11 | The health benefits, side effects and risks have been considered in formulating the recommendations |
Item 12 | There is an explicit link between the recommendations and the supporting evidence |
Item 13 | The guideline has been externally reviewed by experts prior to its publication |
Item 14 | A procedure for updating the guideline is provided |
Domain 4: Clarity of Presentation | |
Item 15 | The recommendations are specific and unambiguous |
Item 16 | The different options for management of the condition or health issue are clearly presented |
Item 17 | Key recommendations are easily identifiable |
Domain 5: Applicability | |
Item 18 | The guideline describes facilitators and barriers to its application |
Item 19 | The guideline provides advice and/or tools on how the recommendations can be put into practice |
Item 20 | The potential resource implications of applying the recommendations have been considered |
Item 21 | The guideline presents monitoring and/or auditing criteria |
Domain 6: Editorial Independence | |
Item 22 | The views of the funding body have not influenced the content of the guideline |
Item 23 | Competing interests of guideline development group members have been recorded and addressed |